Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

She Tian

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101186585. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 8

  1. Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522. First author DOI 10.1111/ajco.14048↗
  2. HOXC4 promotes proliferation of pancreatic cancer cells by increasing LDHA-mediated glycolysis. Co-author DOI 10.18632/aging.206008↗
  3. CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of P… Co-author DOI 10.7150/jca.69617↗
  4. MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12. Co-author DOI 10.1186/s13046-019-1105-3↗
  5. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Co-author DOI 10.18632/oncotarget.14360↗
  6. TRIM37 promoted the growth and migration of the pancreatic cancer cells. First author DOI 10.1007/s13277-015-4078-7↗
  7. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5217-5↗
  8. Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis. Co-author DOI 10.5301/jbm.5000172↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chao Yu · 5 shared papers, 2016–2024 · strength 0.59
  2. Yuting Guo · 2 shared papers, 2022–2024 · strength 0.46
  3. Jianxin Jiang · 4 shared papers, 2016–2019 · strength 0.34
  4. Chengyi Sun · 3 shared papers, 2016–2019 · strength 0.27
  5. Li Liu · 1 shared paper, 2024 · strength 0.26
  6. Shi Zuo · 1 shared paper, 2024 · strength 0.26
  7. Hao Zhang · 1 shared paper, 2024 · strength 0.26
  8. Cheng-Yi Sun · 1 shared paper, 2024 · strength 0.26
  9. Liwen Chen · 1 shared paper, 2024 · strength 0.26
  10. Chengyi Sun · 1 shared paper, 2022 · strength 0.20
  11. Dan Li · 1 shared paper, 2022 · strength 0.20
  12. Xingjun Guo · 2 shared papers, 2017–2019 · strength 0.19
  13. Meiyuan Chen · 2 shared papers, 2016 · strength 0.15
  14. Chengyi Sun · 2 shared papers, 2016 · strength 0.14
  15. Shiyu Chen · 1 shared paper, 2019 · strength 0.10
  16. Zhiwei He · 1 shared paper, 2019 · strength 0.10
  17. Hao Zhang · 1 shared paper, 2016 · strength 0.07
  18. Yaozhen Pan · 1 shared paper, 2016 · strength 0.07
  19. Huajian Gu · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.